The Annual Reports provide a comprehensive overview of Octapharma, explaining who we are and what we do, as well as highlighting our progress against our strategic priorities and financial results.
Family-owned since being established in 1983, Octapharma is a global healthcare company reaching hundreds of thousands of patients every year.
Our passion drives us to provide new health solutions advancing human life. The importance of this is ever more evident this year with the advent of the global pandemic. We continue our mission to help even more people in need through the strength and resilience of all our employees.
"The COVID-19 global pandemic has re-shaped much of our lives, but I am proud to report that Octapharma has not only risen to every challenge but continued to evolve and grow."
"We have delivered yet another excellent performance in 2020, with strong sales growth and robust profitability despite the challenges."
The COVID-19 pandemic affected every part of our business, from plasma collection, to our supply chain, production and engagement with key stakeholders.
However, our employees across the business rallied to mitigate the worst effects of the crisis and, through close collaboration and thousands of individual actions, continued to produce and deliver life-saving medications on behalf of tens of thousands of patients who rely on them, while successfully executing on our strategy for profitable organic growth.
Download the Octapharma Annual Reports in English, French, German and Spanish, which also contain our complete audited financial statements.